Filtered By:
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 5132 results found since Jan 2013.
Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction
CONCLUSION: Among patients with persistent COVID-related OD, our study showed no clear evidence of relative short-term or long-term olfactory recovery among patients receiving high doses of O3FA supplementation.PMID:37261995 | DOI:10.1177/19458924231174799
Source: American Journal of Rhinology and Allergy - June 1, 2023 Category: ENT & OMF Authors: David K Lerner Katherine L Garvey Annie Arrighi-Allisan Evan Kominsky Andrey Filimonov Abdurrahman Al-Awady Peter Filip Katherine Liu Sen Ninan Todd Spock Benjamin Tweel Maaike van Gerwen Madeleine Schaberg Patrick Colley Anthony Del Signore Satish Govind Source Type: research
The controversial effect of smoking and nicotine in SARS-CoV-2 infection
The effects of nicotine and cigarette smoke in many diseases, notably COVID-19 infection, are being debated more frequently. The current basic data for COVID-19 is increasing and indicating the higher risk of ...
Source: Allergy, Asthma and Clinical Immunology - June 1, 2023 Category: Allergy & Immunology Authors: Zahra Salehi, Bibi Fatemeh Nobakht Motlagh Ghoochani, Yazdan Hasani Nourian, Sadegh Azimzadeh Jamalkandi and Mostafa Ghanei Tags: Review Source Type: research
Study provides deeper insight into long COVID
This study is an important step toward defining long COVID beyond any one individual symptom, " said study author Dr. Leora Horwitz, director of the Center for Healthcare Innovation and Delivery Science and co-principal investigator for the RECOVER Clinical Science Core at NYU Langone Health. " This research definition — which may evolve over time — will serve as a foundation for scientific discovery and treatment design. "The researchers say studying the underlying biological mechanisms of long COVID is central to advancing informed interventions and identifying effective treatment strategies.
In addition to establish...
Source: The University of Arizona: Health - May 30, 2023 Category: Universities & Medical Training Authors: mittank Source Type: research
Companies won ’t share COVID-19 shots, stalling future vaccine research
The U.S. government has tens of millions of unused doses of messenger RNA (mRNA) COVID-19 vaccines, regularly trashing shots as they pass their expiration dates. It’s a dismal reflection on recent vaccine uptake, but it’s also a serious roadblock for scientists testing and developing vaccines that could protect against future variants of SARS-CoV-2—and the next pandemic. Developers need existing vaccines as a benchmark to compare with new candidates. But government contracts with the vaccinemakers, and the companies’ own policies, prohibit the use of the vaccines for research purposes.
“At this stage of the ...
Source: ScienceNOW - May 30, 2023 Category: Science Source Type: news
Temporal examination of adult food insecurity amongst Canadian families managing food allergy
Pediatric food allergy is associated with excess familial food costs compared to families without allergy. Since the start of the COVID-19 pandemic, food prices have increased substantially.
Source: Allergy, Asthma and Clinical Immunology - May 27, 2023 Category: Allergy & Immunology Authors: Michael A. Golding, Leslie E. Roos, Elissa M. Abrams, Jennifer D. Gerdts and Jennifer L. P. Protudjer Tags: Letter to the editor Source Type: research
B cells: The many facets of B cells in allergic diseases
B cells play a key role in our immune system through their ability to produce antibodies, suppress a pro-inflammatory state, and contribute to central immune tolerance. We aim to provide an in-depth knowledge of the molecular biology of B cells, including their origin, developmental process, types and subsets, and functions. In allergic diseases, B cells are well-known to induce and maintain immune tolerance through the production of suppressor cytokines such as interleukin-10 (IL-10). Similarly, B cells protect against viral infections such as SARS-CoV-2 that caused the recent COVID-19 pandemic.
Source: Journal of Allergy and Clinical Immunology - May 26, 2023 Category: Allergy & Immunology Authors: Pattraporn Satitsuksanoa, Sayuri Iwasaki, Jolien Boersma, Manal Bel imam, Stephan R. Schneider, Iris Chang, Willem van de Veen, M übeccel Akdis Source Type: research
The COVID-19 virus mutated to outsmart key antibody treatments. Better ones are coming
In 2020, as the COVID-19 pandemic raged and other effective drugs were elusive, monoclonal antibodies (mAbs) emerged as a lifesaving treatment. But now, 3 years later, all the approvals for COVID-19–fighting antibodies have been rescinded in the United States, as mutations of the SARS-CoV-2 virus have left the drugs—which target parts of the original virus—ineffective.
Researchers around the globe are now trying to revive antibody treatments by redesigning them to take aim at targets that are less prone to mutation. “There are new approaches that present a much more challenging task for the virus to evade,” ...
Source: ScienceNOW - May 24, 2023 Category: Science Source Type: news
COVID-19 Incidence and Disease Course Among Patients at an Allergy Department
CONCLUSION: The cumulative COVID-19 incidence in patients from the allergy cohort was higher compared with the general Dutch population, but similar compared with household members. There was no difference in symptoms, disease duration, or hospitalization rate between the allergy cohort and their household members.PMID:37207194 | PMC:PMC10189845 | DOI:10.1177/27534030231172391
Source: Adv Data - May 19, 2023 Category: Epidemiology Authors: Louise E van der Aa Inge S van Egmond Martijn van der Sluijs A A Sophie den Otter Nadie H M Bosmans Sabine E van Beek Angela Hartman Niels A D Guchelaar Paul L A van Daele Maurits S van Maaren P Martin van Hagen Maud A W Hermans Saskia M Rombach Source Type: research
How Providers Are Adjusting to Clinical Care Post-PHE How Providers Are Adjusting to Clinical Care Post-PHE
Physician practices adjust to another new normal as the COVID-19 health emergency ends.Medscape Medical News
Source: Medscape Allergy Headlines - May 18, 2023 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news
Clinical Features of COVID-19 in Patients with Congenital Central Hypoventilation Syndrome
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - May 18, 2023 Category: Respiratory Medicine Authors: Ajay S. Kasi Melinda Riccitelli Sheila S. Kun Adrianna L. Westbrook George L. Silva Thomas G. Keens Lokesh Guglani Source Type: research
Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment
AbstractPurpose of ReviewSince it first appeared, multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been compared to Kawasaki disease (KD). Although there were early parallels between MIS-C and KD, key differences emerged over time. Here, we aim to compare the pathogenesis, clinical presentation, treatment, and outcomes of MIS-C and KD.Recent FindingsIn this article, we review and compare MIS-C and KD, highlighting differentiating features. We discuss the epidemiological and immunological factors along with clinical and laboratory features which discern MIS-C from...
Source: Current Allergy and Asthma Reports - May 12, 2023 Category: Allergy & Immunology Source Type: research
Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination
This study aimed to retrospectively evaluate the role of polyethylene glycol (PEG) sensitivity in vaccination decision-making in pediatric patients at high risk of allergy or with suspected allergic reactions to the first dose of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine. Seventeen enrolled patients were found to have decreased readiness to receive the Coronavirus Disease 2019 (COVID-19) vaccine after developing hypersensitivity to multiple and/or injectable drugs. Skin testing was performed. A basophil activation test with PEG-2000 and 4000 was performed on three patients who were ineligible ...
Source: Allergologia et Immunopathologia - May 11, 2023 Category: Allergy & Immunology Authors: Betul Gemici Karaaslan Nihan Burtecene Ulviye Mustu Suheyla Ocak Ozgur Kasapcopur Ayca K ıykım Haluk Cokugras Source Type: research
